Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

Ashish Goyal; Alex Churkin; Danny Barash; Scott J. Cotler; Amir Shlomai; Ohad Etzion; Harel Dahari

doi:10.1093/ofid/ofac157

Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

Ashish Goyal, Alex Churkin, Danny Barash, Scott J. Cotler, Amir Shlomai, Ohad Etzion, Harel Dahari

Ben-Gurion University of the Negev, Tel Aviv University

Research output: Contribution to journal › Article › peer-review

Abstract

Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.

Original language	American English
Article number	ofac157
Journal	Open Forum Infectious Diseases
Volume	9
Issue number	5
DOIs	https://doi.org/10.1093/ofid/ofac157
State	Published - 1 May 2022

Keywords

Direct-acting antivirals
Hepatitis C virus
Mathematical modeling
Response-guided therapy
Time to cure

All Science Journal Classification (ASJC) codes

Oncology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ofid/ofac157

Cite this

@article{44641be8fa9b4632b93098294abdb93a,

title = "Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration",

abstract = "Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.",

keywords = "Direct-acting antivirals, Hepatitis C virus, Mathematical modeling, Response-guided therapy, Time to cure",

author = "Ashish Goyal and Alex Churkin and Danny Barash and Cotler, \{Scott J.\} and Amir Shlomai and Ohad Etzion and Harel Dahari",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Oxford University Press on behalf of Infectious Diseases Society of America.",

year = "2022",

month = may,

day = "1",

doi = "10.1093/ofid/ofac157",

language = "American English",

volume = "9",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

AU - Goyal, Ashish

AU - Churkin, Alex

AU - Barash, Danny

AU - Cotler, Scott J.

AU - Shlomai, Amir

AU - Etzion, Ohad

AU - Dahari, Harel

PY - 2022/5/1

Y1 - 2022/5/1

N2 - Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.

AB - Shortening duration of direct-acting antiviral therapy for chronic hepatitis C could provide cost savings, reduce medication exposure, and foster adherence and treatment completion in special populations. The current analysis indicates that measuring hepatitis C virus at baseline and on days 7 and 14 of therapy can identify patients for shortening therapy duration.

KW - Direct-acting antivirals

KW - Hepatitis C virus

KW - Mathematical modeling

KW - Response-guided therapy

KW - Time to cure

UR - http://www.scopus.com/inward/record.url?scp=85130365120&partnerID=8YFLogxK

U2 - 10.1093/ofid/ofac157

DO - 10.1093/ofid/ofac157

M3 - Article

C2 - 35493122

SN - 2328-8957

VL - 9

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

IS - 5

M1 - ofac157

ER -

Modeling-Based Response-Guided DAA Therapy for Chronic Hepatitis C to Identify Individuals for Shortening Treatment Duration

Abstract

Keywords

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this